XML 70 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Note 8 - Share Capital (Details Textual)
3 Months Ended 6 Months Ended
Apr. 30, 2021
CAD ($)
$ / shares
shares
Apr. 30, 2022
CAD ($)
$ / shares
shares
Apr. 30, 2021
CAD ($)
shares
Apr. 30, 2022
CAD ($)
$ / shares
shares
Apr. 30, 2021
CAD ($)
shares
Jan. 31, 2022
Oct. 31, 2021
shares
Jan. 31, 2021
Oct. 31, 2020
Statement Line Items [Line Items]                  
Term of share option for share-based payment arrangement (Year)       5 years          
Vesting period of share options for share-based payment arrangement (Year)       3 years          
Maximum number of instruments authorized in share-based payment arrangement (in shares)   1,240,000   1,240,000          
Number of share options outstanding in share-based payment arrangement at end of period 42,017 953,730 42,017 953,730 42,017 953,730 40,000 42,017 42,017
Total expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets | $   $ 424,000 $ 0 $ 620,000 $ 0        
Number of share options granted in share-based payment arrangement   0 0 913,730 0        
Risk free interest rate, share options granted       1.26%          
Option life, share options granted       3.5          
Expected volatility, share options granted       29.50%          
Expected dividend as percentage, share options granted       0.64%          
Forfeiture rate, share options granted       2.00%          
Weighted average share price, share options granted (in CAD per share) | $ / shares       $ 3.10          
Number of share options exercisable in share-based payment arrangement   40,000   40,000          
Weighted average exercise price of share options exercisable in share-based payment arrangement (in CAD per share) | $ / shares   $ 7.00   $ 7.00          
Ordinary shares [member]                  
Statement Line Items [Line Items]                  
Number of shares outstanding at end of period (in shares)   27,441,082   27,441,082     27,441,082    
Series 1 preferred shares [member]                  
Statement Line Items [Line Items]                  
Number of shares outstanding at end of period (in shares)   1,461,460   1,461,460     1,461,460    
Series 3 preferred shares [member]                  
Statement Line Items [Line Items]                  
Number of shares outstanding at end of period (in shares) 1,681,320   1,681,320   1,681,320        
Preference shares, conversion price (in CAD per share) | $ / shares $ 10.00                
Payments for redemption of preference shares | $ $ 16,800,000                
Share issue related cost | $ $ 1,100,000